Kripthonite Therapeutics
Kripthonite Therapeutics Aps develops a therapy that eliminates oxygen-depleted cancer cells in patients with solid tumors. Oxygen-depletion heightens the most aggressive features of cancers and results in resistance towards radio-, chemo-, and immunotherapy. Our therapy derails energy metabolism in oxygen-depleted cancer cells, which leads to rapid and selective cancer cell killing in vitro and in vivo.
Private Company
Funding information not available
About
Kripthonite Therapeutics Aps develops a therapy that eliminates oxygen-depleted cancer cells in patients with solid tumors. Oxygen-depletion heightens the most aggressive features of cancers and results in resistance towards radio-, chemo-, and immunotherapy. Our therapy derails energy metabolism in oxygen-depleted cancer cells, which leads to rapid and selective cancer cell killing in vitro and in vivo.